Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Reports Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning.

Sort by


Neisseria meningitidis Infections - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H1 2016’, provides an overview of the Neisseria meningitidis Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neisseria meningitidis Infections,...
$ 2,000.00 Read More

Klebsiella pneumoniae Infections - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H1 2016’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Klebsiella pneumoniae Infections, co...
$ 2,000.00 Read More

H1N1 Infection - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2016’, provides an overview of the H1N1 Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for H1N1 Infection, complete with analysis by stage of development, drug tar...
$ 2,000.00 Read More

Bone Metastasis - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H1 2016’, provides an overview of the Bone Metastasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bone Metastasis, complete with analysis by stage of development, drug ...
$ 2,000.00 Read More

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Relapsing ...
$ 2,000.00 Read More

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chagas Disease (Am...
$ 2,000.00 Read More

Chikungunya - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Chikungunya - Pipeline Review, H1 2016’, provides an overview of the Chikungunya pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chikungunya, complete with analysis by stage of development, drug target, mech...
$ 2,000.00 Read More

Contact Dermatitis - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H1 2016’, provides an overview of the Contact Dermatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Contact Dermatitis, complete with analysis by stage of developme...
$ 2,000.00 Read More

Acinetobacter Infections - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H1 2016’, provides an overview of the Acinetobacter Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acinetobacter Infections, complete with analysis by ...
$ 2,000.00 Read More

Shigella Infections (Shigellosis) - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H1 2016’, provides an overview of the Shigella Infections (Shigellosis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Shigella Infections (Shigellosis),...
$ 2,000.00 Read More

Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016’, provides an overview of the Leber Congenital Amaurosis (LCA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leber Congenital Amaurosis (LCA), co...
$ 2,000.00 Read More

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Recurrent Glioblastoma...
$ 2,000.00 Read More

Japanese Encephalitis - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H1 2016’, provides an overview of the Japanese Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Japanese Encephalitis, complete with analysis by stage of ...
$ 2,000.00 Read More

Orbis Biosciences, Inc. - Product Pipeline Review - 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Orbis Biosciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Orbis Biosciences, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Orbis Biosciences, I...
$ 1,500.00 Read More

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H1 2016’, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C pipeline landscape. The report provides comprehensive information on the therapeutic...
$ 2,000.00 Read More
Total 2985 records.